Citrin deficiency, a perplexing global disorder

David Dimmock, Bruno Maranda, Carlo Dionisi-Vici, Jing Wang, Soledad Kleppe, Giuseppe Fiermonte, Renkui Bai, Bryan Hainline, Ada Hamosh, William E. O'Brien, Fernando Scaglia, Lee Jun Wong

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Citrin deficiency, caused by mutations in SLC25A13, can present with neonatal intrahepatic cholestasis or with adult onset neuropsychiatric, hepatic and pancreatic disease. Until recently, it had been thought to be found mostly in individuals of East Asian ancestry. A key diagnostic feature has been the deficient argininosuccinate synthetase (ASS) activity (E.C. 6.3.4.5) in liver, with normal activity in skin fibroblasts. In this series we describe the clinical presentation of 10 patients referred to our laboratories for sequence analysis of the SCL25A13 gene, including several patients who presented with elevated citrulline on newborn screening. In addition to sequence analysis performed on all patients, ASS enzyme activity, citrulline incorporation and Western blot analysis for ASS and citrin were performed on skin fibroblasts if available. We have found 5 unreported mutations including two apparent founder mutations in three unrelated French-Canadian patients. In marked contrast to previous cases, these patients have a markedly reduced ASS activity in skin fibroblasts. The presence of citrin protein on Western blot in three of our cases reduces the sensitivity of a screening test based on protein immunoblotting. The finding of citrin mutations in patients of Arabic, Pakistani, French Canadian and Northern European origins supports the concept that citrin deficiency is a panethnic disease.

Original languageEnglish
Pages (from-to)44-49
Number of pages6
JournalMolecular Genetics and Metabolism
Volume96
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Argininosuccinate Synthase
Fibroblasts
Citrulline
Skin
Mutation
Screening
Sequence Analysis
Western Blotting
Intrahepatic Cholestasis
Enzyme activity
Pancreatic Diseases
Liver
Immunoblotting
Proteins
Genes
Adult-onset citrullinemia type 2
citrin
Newborn Infant
Enzymes

Keywords

  • Bipolar disorder
  • Citrullinemia
  • CTLN2
  • Hepatic steatosis
  • Intrahepatic cholestasis
  • Newborn screening
  • NICCD
  • Therapy

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Dimmock, D., Maranda, B., Dionisi-Vici, C., Wang, J., Kleppe, S., Fiermonte, G., ... Wong, L. J. (2009). Citrin deficiency, a perplexing global disorder. Molecular Genetics and Metabolism, 96(1), 44-49. https://doi.org/10.1016/j.ymgme.2008.10.007

Citrin deficiency, a perplexing global disorder. / Dimmock, David; Maranda, Bruno; Dionisi-Vici, Carlo; Wang, Jing; Kleppe, Soledad; Fiermonte, Giuseppe; Bai, Renkui; Hainline, Bryan; Hamosh, Ada; O'Brien, William E.; Scaglia, Fernando; Wong, Lee Jun.

In: Molecular Genetics and Metabolism, Vol. 96, No. 1, 01.2009, p. 44-49.

Research output: Contribution to journalArticle

Dimmock, D, Maranda, B, Dionisi-Vici, C, Wang, J, Kleppe, S, Fiermonte, G, Bai, R, Hainline, B, Hamosh, A, O'Brien, WE, Scaglia, F & Wong, LJ 2009, 'Citrin deficiency, a perplexing global disorder', Molecular Genetics and Metabolism, vol. 96, no. 1, pp. 44-49. https://doi.org/10.1016/j.ymgme.2008.10.007
Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G et al. Citrin deficiency, a perplexing global disorder. Molecular Genetics and Metabolism. 2009 Jan;96(1):44-49. https://doi.org/10.1016/j.ymgme.2008.10.007
Dimmock, David ; Maranda, Bruno ; Dionisi-Vici, Carlo ; Wang, Jing ; Kleppe, Soledad ; Fiermonte, Giuseppe ; Bai, Renkui ; Hainline, Bryan ; Hamosh, Ada ; O'Brien, William E. ; Scaglia, Fernando ; Wong, Lee Jun. / Citrin deficiency, a perplexing global disorder. In: Molecular Genetics and Metabolism. 2009 ; Vol. 96, No. 1. pp. 44-49.
@article{3ab03a290e2f486b9df604f82e0f6f42,
title = "Citrin deficiency, a perplexing global disorder",
abstract = "Citrin deficiency, caused by mutations in SLC25A13, can present with neonatal intrahepatic cholestasis or with adult onset neuropsychiatric, hepatic and pancreatic disease. Until recently, it had been thought to be found mostly in individuals of East Asian ancestry. A key diagnostic feature has been the deficient argininosuccinate synthetase (ASS) activity (E.C. 6.3.4.5) in liver, with normal activity in skin fibroblasts. In this series we describe the clinical presentation of 10 patients referred to our laboratories for sequence analysis of the SCL25A13 gene, including several patients who presented with elevated citrulline on newborn screening. In addition to sequence analysis performed on all patients, ASS enzyme activity, citrulline incorporation and Western blot analysis for ASS and citrin were performed on skin fibroblasts if available. We have found 5 unreported mutations including two apparent founder mutations in three unrelated French-Canadian patients. In marked contrast to previous cases, these patients have a markedly reduced ASS activity in skin fibroblasts. The presence of citrin protein on Western blot in three of our cases reduces the sensitivity of a screening test based on protein immunoblotting. The finding of citrin mutations in patients of Arabic, Pakistani, French Canadian and Northern European origins supports the concept that citrin deficiency is a panethnic disease.",
keywords = "Bipolar disorder, Citrullinemia, CTLN2, Hepatic steatosis, Intrahepatic cholestasis, Newborn screening, NICCD, Therapy",
author = "David Dimmock and Bruno Maranda and Carlo Dionisi-Vici and Jing Wang and Soledad Kleppe and Giuseppe Fiermonte and Renkui Bai and Bryan Hainline and Ada Hamosh and O'Brien, {William E.} and Fernando Scaglia and Wong, {Lee Jun}",
year = "2009",
month = "1",
doi = "10.1016/j.ymgme.2008.10.007",
language = "English",
volume = "96",
pages = "44--49",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Citrin deficiency, a perplexing global disorder

AU - Dimmock, David

AU - Maranda, Bruno

AU - Dionisi-Vici, Carlo

AU - Wang, Jing

AU - Kleppe, Soledad

AU - Fiermonte, Giuseppe

AU - Bai, Renkui

AU - Hainline, Bryan

AU - Hamosh, Ada

AU - O'Brien, William E.

AU - Scaglia, Fernando

AU - Wong, Lee Jun

PY - 2009/1

Y1 - 2009/1

N2 - Citrin deficiency, caused by mutations in SLC25A13, can present with neonatal intrahepatic cholestasis or with adult onset neuropsychiatric, hepatic and pancreatic disease. Until recently, it had been thought to be found mostly in individuals of East Asian ancestry. A key diagnostic feature has been the deficient argininosuccinate synthetase (ASS) activity (E.C. 6.3.4.5) in liver, with normal activity in skin fibroblasts. In this series we describe the clinical presentation of 10 patients referred to our laboratories for sequence analysis of the SCL25A13 gene, including several patients who presented with elevated citrulline on newborn screening. In addition to sequence analysis performed on all patients, ASS enzyme activity, citrulline incorporation and Western blot analysis for ASS and citrin were performed on skin fibroblasts if available. We have found 5 unreported mutations including two apparent founder mutations in three unrelated French-Canadian patients. In marked contrast to previous cases, these patients have a markedly reduced ASS activity in skin fibroblasts. The presence of citrin protein on Western blot in three of our cases reduces the sensitivity of a screening test based on protein immunoblotting. The finding of citrin mutations in patients of Arabic, Pakistani, French Canadian and Northern European origins supports the concept that citrin deficiency is a panethnic disease.

AB - Citrin deficiency, caused by mutations in SLC25A13, can present with neonatal intrahepatic cholestasis or with adult onset neuropsychiatric, hepatic and pancreatic disease. Until recently, it had been thought to be found mostly in individuals of East Asian ancestry. A key diagnostic feature has been the deficient argininosuccinate synthetase (ASS) activity (E.C. 6.3.4.5) in liver, with normal activity in skin fibroblasts. In this series we describe the clinical presentation of 10 patients referred to our laboratories for sequence analysis of the SCL25A13 gene, including several patients who presented with elevated citrulline on newborn screening. In addition to sequence analysis performed on all patients, ASS enzyme activity, citrulline incorporation and Western blot analysis for ASS and citrin were performed on skin fibroblasts if available. We have found 5 unreported mutations including two apparent founder mutations in three unrelated French-Canadian patients. In marked contrast to previous cases, these patients have a markedly reduced ASS activity in skin fibroblasts. The presence of citrin protein on Western blot in three of our cases reduces the sensitivity of a screening test based on protein immunoblotting. The finding of citrin mutations in patients of Arabic, Pakistani, French Canadian and Northern European origins supports the concept that citrin deficiency is a panethnic disease.

KW - Bipolar disorder

KW - Citrullinemia

KW - CTLN2

KW - Hepatic steatosis

KW - Intrahepatic cholestasis

KW - Newborn screening

KW - NICCD

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=57449098390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57449098390&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2008.10.007

DO - 10.1016/j.ymgme.2008.10.007

M3 - Article

C2 - 19036621

AN - SCOPUS:57449098390

VL - 96

SP - 44

EP - 49

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -